Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA Approves 1st Non-Opioid Pain Medicine in 20 Years
What Is Journavx? First Pain Medication Approved by FDA in Over Two Decades
This milestone marks a breakthrough after unsuccessful attempts to develop painkillers without the addictive potential of opioids.
FDA approves painkiller designed to eliminate the risk of addiction associated with opioids
U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioids.
FDA approves new, non-opioid painkiller Journavx
The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller to win FDA approval in more than 20 years.
FDA, migraine and Symbravo
US FDA approves Axsome Therapeutics' migraine drug
The U.S. Food and Drug Administration has approved Axsome Therapeutics' migraine treatment, the company said on Thursday.
Axsome Therapeutics announces FDA approval of Symbravo
Axsome Therapeutics (AXSM) announced that the U.S. FDA has approved Symbravo for the acute treatment of migraine with or without aura in
FDA approves new migraine treatment SYMBRAVO
NEW YORK - Axsome Therapeutics, Inc. (NASDAQ:AXSM), a $5.28 billion biopharmaceutical company with impressive 51% revenue growth over the last twelve months, announced the U.S. Food and Drug Administration (FDA) has approved SYMBRAVO®,
FDA upgrades recall of Lay's potato chips
This chocolate recall has been upgraded to FDA’s highest risk level
STATEN ISLAND, N.Y. — A December 2024 chocolate recall has been upgraded to highest risk level by the U.S. Food and Drug Administration (FDA), which says consuming the product could “cause serious adverse health consequences or death.”
Lay's potato chips recall upgraded to FDA's most serious level. Is Ohio affected?
The FDA elevated Lay's Classic Potato Chips to the highest risk level. Here what to know, and whether the recall impacts Ohio.
FDA reclassifies Lay’s potato chips recall to the highest risk level, warning the chips could cause ‘serious adverse health consequences or death’
The FDA has raised the risk level on a recall of Lay’s potato chips to the highest level, warning the recalled product could cause death. The chips were originally recalled last month for containing undeclared milk.
chronic kidney disease, FDA and Ozempic
FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients
Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the US Food and Drug Administration to reduce certain risks associated with chronic kidney disease,
Doctors Can Now Prescribe Ozempic to Reduce Kidney Disease Risks in Diabetes Patients
Fact checked by Jillian Dara The Food and Drug Administration (FDA) on Tuesday approved Ozempic (semaglutide) to reduce the risk of complications and death in adults with both type 2 diabetes and chronic kidney disease.
FDA approves Ozempic to reduce risk of kidney disease progression, cardiovascular death
The Food and Drug Administration approved Ozempic to be used to lessen the risk of kidney disease from getting worse, end-stage kidney disease and cardiovascular disease-caused death for patients with type 2 diabetes and Dr.
2h
on MSN
FDA approves first new type of pain medication in 25 years
A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...
5h
US FDA Identifies Cybersecurity Risks in Certain Patient Monitors
(Reuters) - The U.S. Food and Drug Administration (FDA) said on Thursday it had identified three cybersecurity risks ...
1d
on MSN
Chocolate Recall Update As FDA Sets Highest Risk Level for 9 States
A recall which was issued across nine states has now been given the highest risk classification by the federal agency.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
All aboard feared dead
Los Angeles wildfire updates
Blames DEI for crash
Bird flu 'widespread' in MA
Shot dead in Sweden
Gets 11 years in prison
DOJ weighs dropping case?
Shiffrin finishes 10th
FDA upgrades recall
Ex-FDNY chief pleads guilty
Agency halts events
Jury weighs charges
Witkoff meets Netanyahu
Appoints acting commissioner
In talks to invest in OpenAI
Zeldin confirmed by Senate
Plans job, output cuts in US
Pushes for earlier trial
Day 2 of Senate hearing
Fall behind in reading
Asteroid may hit Earth
First spacewalk together
US economy grew 2.3%
Gun trafficking indictments
Ebola outbreak in Uganda
DOJ sues to block deal
Senate confirmation hearing
Searching for joyriders
Weekly jobless claims fall
Nashville bids for franchise
Agrees to settle Trump suit
Hamas frees more hostages
Syria’s transitional pres
Signs education orders
'As Tears Go By' singer dies
'The Voice' alum dies at 44
Lawsuit to keep records
Wildfire erupts in NC
KY deputy shooting sentence
Victims of DC plane crash
Ex-worker admits to theft
Presidential historian dies
Related topics
Trump
Washington
United States
Food and Drug Administration
Journavx
Feedback